Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet

Although the prevalence of non-alcoholic fatty liver disease (NAFLD) continues to increase, there is no effective treatment approved for this condition. We previously showed, in high-fat diet (HFD)-fed mice, that the supplementation of combined metabolic activators (CMA), including nicotinamide ribo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Mayneris-Perxachs, Jordi, Boqué, Noemí, del Bas, Josep M., Arola, Lluís, Yuan, Meng, Türkez, Hasan, Uhlén, Mathias, Borén, Jan, Zhang, Cheng, Mardinoglu, Adil, Caimari, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533474/
https://www.ncbi.nlm.nih.gov/pubmed/34680557
http://dx.doi.org/10.3390/biomedicines9101440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533474/
https://www.ncbi.nlm.nih.gov/pubmed/34680557
http://dx.doi.org/10.3390/biomedicines9101440

Ejemplares similares